Lymphomyosot
FDA Label NDC 62795-9491

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Lymphomyosot (NDC 62795-9491). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings:, keep out of reach of children, purpose, active ingredients:, inactive ingredients:, directions, indications:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings:

 If pregnant or breast-feeding, ask
a health professional before use. Keep out of
reach of children. If symptoms persist or worsen,
a health professional should be consulted. Do not
use if known sensitivity to Lymphomyosot® or any
of its ingredients exists.

Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN

Purpose

Lymph
Support

Active Ingredients:

 Each 300 mg tablet contains:
*Aranea diadema 6X 15mg; Calcarea phosphorica 12X
15mg; *Equisetum hyemale 4X 15mg; Ferrum iodatum
12X 30mg; *Fumaria officinalis 4X 15mg; *Gentiana
lutea 5X 15mg; *Geranium robertianum 4X 30mg;
*Juglans regia 3X 15mg; Levothyroxinum 12X 15mg;
*Myosotis arvensis 3X 15mg; *Nasturtium aquaticum
4X 30mg; Natrum sulphuricum 4X 15mg; *Pinus
sylvestris 4X 15mg; *Sarsaparilla 6X 15mg;
*Scrophularia nodosa 3X 15mg; *Teucrium scorodonia
3X 15mg; *Veronica officinalis 3X 15mg. *Natural

Inactive Ingredients:

 Lactose, Magnesium stearate

Directions

Adults and children 4 years and
older: 1-2 tablets 3 times per day or as directed by a
health practitioner. Not to exceed 6 tablets per 24
hours. Children under 4, as directed by a health
professional. Allow to completely dissolve in the mouth.

Indications:

For lymph support when experiencing
minor cold and flu symptoms.

* Please review the disclaimer below.